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Background: Genetic influences on gene expression in the human fetal brain plausibly impact upon a variety of
postnatal brain-related traits, including susceptibility to neuropsychiatric disorders. However, to date, there have
been no studies that have mapped genome-wide expression quantitative trait loci (eQTL) specifically in the human
prenatal brain.
Results: We performed deep RNA sequencing and genome-wide genotyping on a unique collection of 120 human
brains from the second trimester of gestation to provide the first eQTL dataset derived exclusively from the human
fetal brain. We identify high confidence cis-acting eQTL at the individual transcript as well as whole gene level,
including many mapping to a common inversion polymorphism on chromosome 17q21. Fetal brain eQTL are
enriched among risk variants for postnatal conditions including attention deficit hyperactivity disorder,
schizophrenia, and bipolar disorder. We further identify changes in gene expression within the prenatal brain that
potentially mediate risk for neuropsychiatric traits, including increased expression of C4A in association with genetic
risk for schizophrenia, increased expression of LRRC57 in association with genetic risk for bipolar disorder, and
altered expression of multiple genes within the chromosome 17q21 inversion in association with variants
influencing the personality trait of neuroticism.
Conclusions: We have mapped eQTL operating in the human fetal brain, providing evidence that these confer risk
to certain neuropsychiatric disorders, and identifying gene expression changes that potentially mediate
susceptibility to these conditions.Background
Results from genome-wide association studies (GWAS)
have established an important role for common
non-coding genetic variation in complex diseases [1, 2].
These associations are likely to reflect variants that influ-
ence gene expression, through effects on RNA transcrip-
tion, splicing, or stability. By combining genome-wide
genotyping with transcriptome profiling, variants* Correspondence: BrayN3@Cardiff.ac.uk
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a genomic scale as expression quantitative trait loci
(eQTL) [3, 4]. Although eQTL are often shared between
tissues, they can also operate in a tissue-specific manner
[4–6], as a result of cellular differences in the expression
of the trans-regulators that interact with these loci [7], as
well as in the epigenetic modification and accessibility of
the regulatory elements in which they are located [8, 9].
Genetic influences on gene regulation that are active
during human prenatal brain development plausibly im-
pact upon a variety of postnatal, brain-related pheno-
types. For example, we have previously shown that
genetic variants associated with DNA methylation in the
human fetal brain are enriched among variants associ-
ated with schizophrenia [10], a severe psychiatricle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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component [11, 12]. Common genetic variants associ-
ated with schizophrenia are also reported to be enriched
within open chromatin (an index of regulatory regions)
in the developing human cerebral cortex [13], and there
are reports of association between gene expression in
fetal brain and schizophrenia risk alleles at individual
loci, e.g., [6, 14]. However, apart from one previous in-
vestigation that included a relatively small subset of fetal
brains (n = 38) [15], no study has explored genetic effects
on gene expression in the human prenatal brain on a
genome-wide scale.
In the present study, we carried out deep RNA se-
quencing and genome-wide genotyping on a large col-
lection of human brains from the second trimester of
gestation (n = 120), providing the first eQTL dataset de-
rived exclusively from the prenatal human brain. We
identify high confidence cis-acting eQTL at the individ-
ual transcript as well as whole gene level, including
many mapping to a common inversion polymorphism
on chromosome 17q21. We further show that fetal brain
eQTL are enriched among risk variants for neuropsychi-
atric disorders and identify genetically influenced
changes in gene expression within the developing brain
that potentially mediate risk for these conditions.
Results
We performed strand-specific, whole transcriptome se-
quencing of total RNA derived from brain tissue from
120 human fetuses aged 12–19 post-conception weeks
(PCW), generating a median 119 million read pairs per
sample (Additional file 1: Table S1). Expression measures
were derived for 144,448 Ensembl transcripts, annotated
to 28,875 genes. Genomic DNA from each sample was
genotyped for approximately 710,000 single nucleotide
polymorphisms (SNPs), followed by genotype imputation
using the Haplotype Reference Consortium r1.1 panel
[16]. After strict quality control, 5.8 million SNPs were
retained for analysis. Consistent with the GTEx Consor-
tium [4], we controlled gene expression measures for la-
tent factors using probabilistic estimation of expression
residuals (PEER) [17] in addition to specified covariates
and principal components from the genotyping matrix
(Additional file 2: Figure S1 and Figure S2). Cis-eQTL
were identified by linear regression of allele dosage
against adjusted, quantile-normalized gene expression
measures using FastQTL [18].
Characterization of cis-eQTL in the human fetal brain
We identified cis-eQTL (defined as variants within 1 Mb
of the transcription start site [TSS] of the regulated gene)
associated with the fetal brain expression of 1329 genes
(eGenes) and 3252 individual transcripts (eTranscripts) at
a false discovery rate (FDR) < 0.05 (Additional file 1: TableS2 and Table S3). The majority (86%) of eQTL detected at
the whole gene level were also detected at the individual
transcript level. Consistent with previous eQTL mapping
studies [5, 15, 19], significant eQTL were concentrated in
proximity to the TSS of the regulated transcript (Fig. 1a).
We further tested for enrichment of high confidence
cis-eQTLs (FDR < 0.05) within functional annotations pro-
vided by the ENCODE [8] and Roadmap Epigenomics
Consortium [9] projects (Additional file 1: Table S4 and
Table S5). Fetal brain cis-eQTL were significantly enriched
within regions annotated as TSS, flanking promoters,
enhancers, weak enhancers, and CTCF binding sites, but
significantly depleted in repressed regions (Fig. 1b). Identi-
fied cis-eQTL were also notably enriched within regions
containing histone modifications indicative of regulatory
activity (Additional file 2: Figure S3). We additionally
tested for enrichment, among our high confidence
cis-eQTL, of variants that we have previously found to be
associated with altered DNA methylation (mQTL) in the
human fetal brain [10]. Consistent with an association be-
tween DNA methylation and gene expression [20, 21],
fetal brain mQTL were enriched sixfold among fetal brain
cis-eQTL (P = 3.13 × 10− 19).
eQTL at a common inversion polymorphism on
chromosome 17q21
Twenty-one of the cis-eQTL eGenes identified in fetal
brain are located within a region of chromosome
17q21.31 containing a common 900-kb inversion poly-
morphism and several common duplications [22, 23].
Variants within this inversion (denoted “H2”), which ap-
pears to be under positive selection in Europeans [22],
have recently been implicated in neuroticism [24–26],
while markers on the non-inverted form (denoted “H1”)
are associated with several neurodegenerative diseases
[27–29]. For 13 of the eGenes in this region (e.g.,
KANSL1, LRRC37A, DND1P1), cis-eQTL could be
largely explained by inversion status (r2 with H1/H2 tag
SNP rs1800547 > 0.9), with variants tagging the inverted
H2 form associated with both increases and decreases in
gene expression (Table 1). For other genes in the region
(e.g., NSF, ARL17A, ARL17B), identified cis-eQTL might
index duplicated expressed gene sequence as well as
regulatory variants that have arisen independently on
the H1 or H2 haplotypes.
Tissue-sharing and evidence for fetal-specific eQTL
We next explored the extent to which cis-eQTL identi-
fied in the fetal brain are shared among 48 adult human
tissues analyzed through the Genotype-Tissue Expres-
sion (GTEx) project [4]. For this, we restricted our ana-
lyses to the eQTL we identified for fetal eGenes as the
GTEx project does not currently provide eQTL data at
the individual transcript level. Of the 1151 fetal brain
A B
Fig. 1 Genomic characterization of fetal brain cis-eQTL. a Plot of eQTL density (FDR < 0.05) versus distance from transcription start site for all
eTranscripts. Expression QTLs mapping to a common 900-kb inversion on chromosome 17q21 were excluded from this analysis due to extensive
linkage disequilibrium across the inversion. b Enrichment of eTranscript eQTL within genomic features identified by the ENCODE [8] and Roadmap
Epigenomics Consortium [9] projects in six human cell lines. Enrichments are expressed as the natural log of odds ratios, with error bars representing
95% confidence intervals. GM12878 = lymphoblastoid cell line; H1HESC = embryonic stem cell line; HeLa-S3 = cervix adenocarcinoma cell line; HepG2
liver carcinoma cell line; HUVEC = umbilical vein endothelial cells; K562 =myeloid leukemia cell line. Fetal brain eQTL are significantly enriched in regions
annotated as TSS, flanking promoter, enhancer, weak enhancer, and CTCF binding sites, but significantly depleted in repressed genomic regions
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979 had a top eQTL (the most significant fetal brain
eQTL for that gene that was genotyped in the GTEx
study) that was also observed in at least one adult tissue
(at FDR < 0.05). The shared eQTL for 974 of these fetal
eGenes were predicted to be active in at least two adult
tissues. Tissue-sharing of fetal brain eQTL was most
pronounced within regions of the adult brain, where an
average of 79% of the tested fetal brain eQTL were pre-
dicted to be shared, and lowest for whole blood, where
only 41% of the tested fetal brain eQTL were predicted
to be shared (Fig. 2). Predicted tissue sharing was sup-
ported by estimates of π1 (the proportion of true posi-
tives [30]) among fetal eQTL when tested for replication
in individual GTEx tissues, with high π1 estimates in
adult brain regions despite relatively small GTEx sample
sizes (Additional file 2: Figure S4). For 172 eGenesassayed by the GTEx Consortium, the eQTL identified
in fetal brain were not associated with significant (FDR
< 0.05) effects on their expression in any sampled adult
tissue, and these might therefore constitute fetal-specific
eQTL (Additional file 1: Table S6).
Regional and developmental expression of fetal eGenes in
the human brain
We used RNA sequencing data from dissected regions of
the human pre- and post-natal brain, available through
the BrainSpan project, to explore the spatiotemporal ex-
pression of the fetal eGenes we identified. In general, fetal
eGenes were expressed fairly uniformly across dissected
regions of both the fetal and adult brain, with some genes
showing very high expression and others very low
(Additional file 2: Figure S5 and Figure S6). Similarly, the
majority of fetal eGenes displayed a reasonably stable
Table 1 Fetal brain eGenes located at a common inversion polymorphism on chromosome 17q21
eGene ENSEMBL ID Number eQTL SNPs FDR < 0.05 Top eQTL Top eQTL
FDR
r2 with inversion* H1/H2 expression ratio
NSF ENSG00000073969 40 rs3874943 4.05E−06 0.14 1.02
KANSL1 ENSG00000120071 2226 rs2668690 2.81E−14 0.94 0.89
LRRC37A ENSG00000176681 2225 rs3785884 5.89E−17 0.97 0.80
ARL17A ENSG00000185829 34 rs1863115 7.03E−04 0.11 1.00
KANSL1-AS1 ENSG00000214401 2215 rs62057151 1.72E−11 0.94 0.81
LRRC37A4P ENSG00000214425 2210 rs55944735 7.40E−12 0.97 1.96
ARL17B ENSG00000228696 48 rs1863115 1.82E−06 0.11 1.02
LRRC37A2 ENSG00000238083 2213 rs753236 7.11E−15 0.94 0.83
NSFP1 ENSG00000260075 54 rs1863115 2.89E−14 0.11 1.22
AC005670.2 ENSG00000262633 1036 rs2696689 4.02E−03 0.65 0.91
MAPK8IP1P2 ENSG00000263503 2276 rs111447859 1.50E−23 0.97 0.39
DND1P1 ENSG00000264070 2199 17:44219831 1.73E−08 0.97 1.38
MAPT-AS1 ENSG00000264589 1816 rs60814418 3.01E−02 0.61 1.15
RN7SL199P ENSG00000265315 2203 rs56180212 2.47E−09 0.97 0.78
RN7SL656P ENSG00000265411 2204 rs56180212 2.17E−09 0.97 0.78
AC138645.1 ENSG00000266497 2218 rs4327090 5.75E−11 0.94 0.82
AC091132.3 ENSG00000266504 2213 rs4327090 5.12E−11 0.94 0.82
AC091132.4 ENSG00000266918 2066 rs9899833 1.55E−02 0.54 1.06
AC091132.5 ENSG00000267198 39 rs79475968 7.94E−05 0.04 1.03
AC091132.6 ENSG00000267246 2253 rs753236 7.61E−11 0.94 0.76
Metazoa_SRP ENSG00000278770 2215 rs4327090 2.30E−09 0.94 1.54
*Consistent with Stefansson et al [22], inversion status was inferred through genotype at SNP rs1800547, with the MAPT haplotype “H2” used to denote the
inversion and “H1” the non-inverted form
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when the associated eQTLs were predicted to be
fetal-specific (Additional file 2: Figure S7). A notable ex-
ception to this pattern was observed in the developmental
expression of the predicted fetal-specific eGene HBG1, en-
coding hemoglobin subunit gamma 1 (a component of
fetal hemoglobin), which showed the expected preponder-
ance in prenatal brain (Additional file 2: Figure S8).
Enrichment of fetal brain cis-eQTL within genetic variants
associated with neuropsychiatric traits
Genetic effects on gene expression operating in the hu-
man fetal brain could influence a variety of post-natal,
brain-related phenotypes. We tested for enrichment
among high confidence fetal brain eQTL (FDR < 0.05) of
variants associated with seven neuropsychiatric traits (at-
tention deficit hyperactivity disorder, anorexia nervosa,
autism spectrum disorder, bipolar disorder, major de-
pressive disorder, neuroticism, and schizophrenia) using
large-scale GWAS data [26, 31–36]. For these analyses,
we focused on transcript-level eQTL as these largely en-
compass those identified at the gene level and are likely
to additionally index subtle regulatory variation (e.g.,
those affecting splicing, or transcript-specific promoters/enhancers) that could be relevant to complex traits [37].
We assessed enrichment among fetal eQTL of
trait-associated variants at four GWAS P value thresh-
olds for each trait (P < 5 × 10− 5, 5 × 10− 6, 5 × 10− 7, and
5 × 10− 8), using a method that accounts for allele fre-
quency, linkage disequilibrium, and local gene density
[38]. As a comparison, we performed identical analyses
on similar sized GWAS data for five non-brain traits
(body mass index, coronary artery disease, inflammatory
bowel disease, height, and type 2 diabetes) [39–43]. Fetal
brain transcript eQTL were notably enriched (P < 0.001)
within trait-associated variants for three neuropsychiatric
disorders (attention deficit hyperactivity disorder, bipolar
disorder, and schizophrenia) and one non-brain trait
(inflammatory bowel disease) at one or more GWAS P
value threshold (Fig. 3; Additional file 1: Table S7).
Identification of gene expression changes in fetal brain
associated with neuropsychiatric traits
Given evidence for a potential role of fetal brain eQTL
in neuropsychiatric traits, we next applied summary
data-based Mendelian randomization (SMR) to identify
genetically influenced changes in gene expression in the
fetal brain that could mediate genetic risk for these
Fig. 2 Heatmap of m values for fetal brain cis-eQTL (FDR < 0.05) for 974 eGenes across 48 adult tissues assayed by the GTEx Consortium [4]. m
values are derived from a Meta-Tissue [68] analysis performed by the GTEx consortium (using v7 data), and estimate the posterior probability that
an eQTL is shared between each tissue. GTEx m values are available for 974 gene fetal brain cis-eQTL that are predicted to be shared by at least
two adult tissues (m values > 0.9); the five fetal brain cis-eQTL that are eQTL in only one adult tissue (FDR < 0.05) are not included. Greatest
sharing of fetal brain eQTL is observed for adult brain regions, where, on average, 79% of the tested fetal brain eQTL are predicted to be shared
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randomization to test for pleiotropic associations be-
tween gene expression and complex traits using eQTL
and trait GWAS summary data [44, 45]. We tested for
joint associations between gene expression and risk for
the seven neuropsychiatric traits (attention deficit hyper-
activity disorder, anorexia nervosa, autism spectrum dis-
order, bipolar disorder, major depressive disorder,
neuroticism, and schizophrenia) using the same GWAS
datasets as we used for enrichment analyses [26, 31–36].
We considered only eGenes and eTranscripts for which
fetal brain eQTL were identified at FDR < 0.05, and re-
port associations that survive correction for multipletests (eGenes, P-SMR = 3.76 × 10− 5; eTranscripts, P-SMR
< 1.54 × 10− 5). In addition, we only report associations
that are non-significant (P > 0.05) for the HEIDI (hetero-
geneity in dependent instruments) test, indicating that they
are unlikely to be driven by linkage between the eQTL and
independent risk variants [44]. In total, we identified 15
eGenes and 34 eTranscripts where expression in fetal brain
was pleiotropically associated with at least one neuro-
psychiatric trait and conformed to the above criteria
(Additional file 1: Table S8 and Table S9, respectively).
We identified 6 eGenes and 14 eTranscripts for which
fetal brain expression was associated with schizophrenia
risk. These include reduced expression of ABCB9,
Fig. 3 Enrichment of fetal brain transcript eQTL within variants associated with complex post-natal traits. Enrichments were tested at four GWAS
P value thresholds (P < 5 × 10− 5, 5 × 10− 6, 5 × 10− 7, and 5 × 10− 8) for each trait. Top panel shows log10 P values at each threshold. The bottom
panel shows the natural log of the odds ratio, with 95% confidence intervals, at each threshold. Only traits for which the significance of eQTL
enrichment survives correction for multiple tests (P < 0.001; dotted line in upper panel) at one or more GWAS P value threshold are shown. There
are no overlaps between fetal brain eQTL and risk variants for bipolar disorder at the P < 5 × 10− 8 threshold
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(P-SMR = 2.11 × 10− 5), which has been previously impli-
cated through SMR studies of schizophrenia GWAS in
blood [44, 46] and other non-brain adult tissues [45],
and increased expression of CSPG4P11, encoding Chon-
droitin Sulfate Proteoglycan 4 Pseudogene 11 (P-SMR =
6.66 × 10− 6), which has also been reported in an SMR
study of adult human brain gene expression data [45].
We also observed association between schizophrenia
and reduced fetal brain expression of a transcript of
KLC1, encoding Kinesin Light Chain 1 (P-SMR = 2.95 ×
10− 7), which has recently been implicated in schizophre-
nia risk through a splicing QTL in the adult brain [47].
The most significant association with schizophrenia
(P-SMR = 6.3 × 10− 8) was in the expression of C4A, en-
coding Complement C4A, which exhibited increased ex-
pression in association with risk variation (Fig. 4).
Genetic association between schizophrenia and the
major histocompatibility complex (MHC) locus on
chromosome 6 has been shown to partly reflect com-
mon gene copy number variants resulting in increased
expression of C4A in the adult human brain [48]. The
present data suggest that pathogenic effects of variation
at the C4 locus might begin in utero. We also observed
several novel associations with schizophrenia, including
reduced expression of transcripts of FLOT1, encodingFlotillin 1 (P-SMR = 5.0 × 10− 7), increased expression of
a transcript of MSANTD2, encoding Myb/SANT DNA
Binding Domain Containing 2 (P-SMR = 2.8 × 10− 6), and
increased expression of HIST1H4L, encoding Histone
Cluster 1 H4 Family Member L (P-SMR = 4.4 × 10− 7).
We observed association between variants influencing
the personality trait of neuroticism and the expression of 7
eGenes and 18 eTranscripts in fetal brain. The majority of
these (4 eGenes and 17 eTranscripts) were located at the
common inversion polymorphism on chromosome 17q21.
The most significant SMR associations were observed for
transcripts of LRRC37A, encoding Leucine Rich Repeat
Containing 37A (smallest P-SMR= 2.33 × 10− 13) and
KANSL1, encoding KAT8 Regulatory NSL Complex Sub-
unit 1 (smallest P-SMR= 8.1 × 10− 12), with variants confer-
ring higher neuroticism scores associated with increased
expression of both genes. The three neuroticism-associated
genes that did not map to the inversion are functionally
uncharacterized, but for one of these genes (AC022784.7),
the cis-eQTL is predicted to be fetal-specific. The only
neuroticism-associated transcript that did not map to
chromosome 17q21 is annotated to the ORC4 gene, encod-
ing Origin Recognition Complex Subunit 4 (P-SMR =
1.91 × 10− 7).
Reduced expression of one transcript, annotated to the
RPL31P12 gene (encoding Ribosomal Protein L31
A B
Fig. 4 Association between expression of the Complement C4A gene in fetal brain and genetic risk for schizophrenia. a Effect sizes of SNPs from
schizophrenia GWAS [36] plotted against their effect sizes as fetal brain cis-eQTL for C4A. The triangular data point indicates the variant with the
lowest P-SMR. Error bars are the standard errors of SNP effects. b Homozygotes for the schizophrenia-associated C-allele of rs9267544 exhibit
increased expression of C4A in fetal brain compared with heterozygotes for this SNP. Error bars represent standard errors
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disorder (P-SMR = 2.19 × 10− 6), while increased expres-
sion of the RPS26 gene (encoding Ribosomal Protein
S26) was associated with genetic risk for anorexia ner-
vosa (P-SMR = 2.34 × 10− 6). Increased expression of the
LRRC57 gene, encoding Leucine Rich Repeat Containing
57, was associated with bipolar disorder (P-SMR =
3.07 × 10− 5). In addition, a transcript annotated to
GNL3, encoding G Protein Nucleolar 3, was associated
with both bipolar disorder (P-SMR = 2.17 × 10− 6) and
schizophrenia (P-SMR = 2.71 × 10− 7), with risk alleles for
both disorders associated with increased expression of
this transcript in fetal brain.
We additionally explored whether eQTLs identified in
the adult human brain (dorsolateral prefrontal cortex)
[49] that have been implicated in neuropsychiatric traits
in a previous SMR study [45] are potentially also operat-
ing in the fetal brain. For four fetal eGenes, we observed
strong linkage disequilibrium in our samples (r2 > 0.8)
between the most significant fetal brain eQTL and the
adult brain eQTL implicated in schizophrenia risk
through SMR (Additional file 1: Table S10). In addition
to CSPG4P11, which showed a significant SMR associ-
ation with schizophrenia in the present study, these in-
cluded CD46, encoding the CD46 complement
regulatory protein, GOLGA2P7, encoding GOLGA2pseudogene 2, and SLCO4C1, encoding Solute Carrier
Organic Anion Transporter Family Member 4C1. There
was no apparent overlap between adult brain eQTL im-
plicated in neuroticism and eQTL regulating the fetal
eGenes identified in this study.
Discussion
We present the first genome-wide eQTL mapping study
performed exclusively on the prenatal human brain.
Through deep RNA sequencing, we have been able to
interrogate eQTL at the individual transcript as well as
whole gene level, providing a more precise elucidation of
common genetic influences on gene expression in the
developing brain and the molecular differences that
could confer susceptibility to neuropsychiatric disorders.
Using a method that controls for the number of SNPs
tested at each locus as well as the number of genes/tran-
scripts assayed [4, 18], we identified high confidence
cis-eQTL regulating 1329 genes and 3252 individual
transcripts in the human fetal brain. This approximates
the number of eGenes identified using the same proced-
ure in adult brain collections of comparable size; for ex-
ample, in 92 samples from the adult frontal cortex, the
GTEx Consortium identified cis-eQTL (FDR < 0.05) for
1588 genes [4]. However, this is likely to constitute only
a small percentage of the genes expressed in fetal brain
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in adult human tissues have indicated that a sizeable
proportion of expressed genes are variably cis-regulated
[4, 50, 51], with eQTL mapping studies showing the ex-
pected strong correlation between eQTL discovery and
sample size [4]. Larger collections of fetal brain are
therefore likely to yield many additional eQTL, with
resulting improvements in power to identify gene ex-
pression changes relevant to brain-related traits.
Many of the fetal brain eQTL we identified map to a
common 900-kb inversion polymorphism on chromo-
some 17q21.31. The eQTL for 13 of the genes in the re-
gion are largely tagged by the inversion, which was
associated with both increases and decreases in gene ex-
pression. Although our analyses of tissue-sharing suggest
that none of the eQTL mapping to this region are spe-
cific to the fetal brain, only one study to our knowledge
has specifically reported any of the gene expression dif-
ferences we observe [52]. This previous study reported
differences between H1 and H2 in the expression of six
genes in the adult human brain, which, congruent with
our data, included increased expression of LRRC37A in
association with the inverted H2 form.
Of the tested neuropsychiatric traits, we observed not-
able enrichment among high confidence fetal brain
eQTL of variants associated with attention deficit hyper-
activity disorder (ADHD), bipolar disorder, and schizo-
phrenia. We also observed nominally significant
enrichment of variants associated with autism at lower
GWAS P value thresholds (Additional file 1: Table S7),
although we note that the number of tested variants for
this was smaller than for other brain-related traits, limit-
ing statistical power. Like autism, ADHD is considered
to be a neurodevelopmental condition, but the genes in-
volved and the developmental timing of their action are
largely unknown. We observed an average 13-fold enrich-
ment of ADHD-associated variants within fetal brain eQTL
across the four GWAS P value thresholds tested, suggesting
an important prenatal genetic component to this condition.
Our finding of an enrichment of schizophrenia-associated
variants among fetal brain eQTL is also consistent with the
long hypothesized early neurodevelopmental component to
this disorder [11, 12]. Although less commonly conceptual-
ized as neurodevelopmental in origin, we observed a similar
enrichment of risk variants for bipolar disorder among high
confidence fetal brain eQTL. In contrast, we observed no
enrichment of risk variants for major depressive disorder,
despite similar numbers of tested risk-associated variants at
each GWAS P value threshold (Additional file 1: Table S7).
Among non-brain traits, the most pronounced enrichment
of fetal brain eQTL was observed for variants associated
with inflammatory bowel disease (average sevenfold enrich-
ment across the four GWAS P value thresholds), suggesting
a developmental component to this condition.The eQTL giving rise to the identified pleiotropic asso-
ciations between gene expression in the fetal brain and
risk for neuropsychiatric disorders do not, for the most
part, appear to be fetal-specific. However, their activity
within the brain at this timepoint makes it plausible that
their pathogenic effects start prenatally, even if they con-
tinue into adulthood. Indeed, several of the genes that we
implicate are known to have important roles in early brain
development. For example, leucine-rich repeat containing
genes (which include LRRC37A, implicated in neuroti-
cism, and LRRC57, implicated in bipolar disorder) are
known to be key organizers of excitatory and inhibitory
synapse formation [53]. Similarly, FLOT1, which exhibited
reduced expression in association with genetic risk for
schizophrenia, has been found to promote the formation
of hippocampal glutamatergic synapses [54], which appear
to be decreased in the disorder [55]. Increased expression
of C4A in association with schizophrenia risk variation
was originally reported in the adult brain [48], where the
authors provided data to support a role for this gene in
synaptic pruning. Although this process is important for
maturation of regions such as the frontal cortex in adoles-
cence, it begins (and is for some brain regions pro-
nounced) during the perinatal period [56]. Our findings
thus suggest that as well as influencing synaptic pruning
during adolescence, effects of C4 risk variation could ini-
tially impact neural connectivity at this early phase of syn-
aptic refinement.
Conclusion
We have mapped high confidence eQTL operating in
the human fetal brain. Although a large proportion of
these continue to operate in adulthood, their activity at
this timepoint and enrichment among risk variants for
certain neuropsychiatric disorders suggest that their in-
fluence on brain-related traits may at least start at this
early stage of development. We identify several genes
and individual transcripts for which expression in the
fetal brain could mediate genetic risk for neuropsychi-
atric traits, and these might therefore warrant further
neurobiological investigation. We have made the sum-
mary eQTL data available [57] so that others can explore
neurodevelopmental antecedents to these and other
brain-related conditions.
Methods
Samples
Human fetal brain tissue from elective terminations of
pregnancy (12–19 PCW) was provided by the Human
Developmental Biology Resource (HDBR) (http://
www.hdbr.org). Fetal age was determined by the HDBR
through foot length and knee-to-heel length measure-
ments. Fetal sex was determined by karyotyping and
confirmed in this study through male-specific expression
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X-chromosome markers in females. No other phenotypic
or demographic information was available. Brain tissue
was obtained frozen and had not been dissected into re-
gions. Total RNA was extracted from half of the avail-
able brain tissue from each fetus using Tri-Reagent
(Thermo Fisher Scientific), while the other half of each
sample was processed for genomic DNA using standard
phenol-chloroform extraction.
Genotyping
Genomic DNA from each sample was genotyped for ap-
proximately 710,000 SNPs using the Infinium
OmniExpress-24 BeadChip array (Illumina). Genotyping
data was subjected to stringent quality control using
PLINK v1.9. and the check-bim utility from http://
www.well.ox.ac.uk/~wrayner/tools/index.html. Samples
with > 5% missing markers, ambiguous sex assignments,
or anomalous heterozygosity were excluded. SNPs that
were missing in > 5% of samples or had minor allele fre-
quency less than 0.01 were removed, as were A/T and
G/C SNPs with minor allele frequencies > 0.4. The SNP
strand and ref/alt assignment were updated to match the
Human Reference Consortium (HRC) version 1.1, and
SNPs where the minor allele frequency differed by > 0.2
from the HRC were removed. Additional genotypes were
imputed from the HRC panel using minimac3 and Eagle
v2.3 phasing through the Michigan Imputation Server
(https://imputationserver.sph.umich.edu/index.html).
SNPs were annotated with rsID numbers from dbSNP
v149 and converted to GRCh38 coordinates using Cross-
Map [58] with chain files from the UCSC Genome
Browser (https://genome.ucsc.edu/). Non-SNP positions
and duplicated sites identified by checkVCF (https://
github.com/zhanxw/checkVCF) were filtered out, as
were sites with an imputation r2 less than 0.8, minor al-
lele frequency less than 0.05, or Hardy-Weinberg Equi-
librium violation P values less than 1 × 10− 4. Genotypes
from DNA were compared with those from RNA se-
quencing to confirm matching of genotype and gene ex-
pression measures for each sample.
RNA sequencing library preparation
Total RNA was treated with TURBO DNase (Thermo
Fisher Scientific) and purified using the RNeasy Micro
kit (Qiagen). Integrity of RNA was assessed using the
Agilent 2100 Bioanalyzer. RNA-Seq libraries were pre-
pared using 1 μg of purified total RNA and the TruSeq
Stranded Total RNA Library Prep kit (Illumina), deplet-
ing ribosomal RNA using the Ribo-Zero Gold reagent
(Illumina), and modifying the RNA fragmentation times
for lower RIN samples (< 7) according to manufacturer
instructions. Library size was assessed using High Sensi-
tivity DNA Analysis kits (Agilent) on the Agilent 2100Bioanalyzer and libraries quantified using KAPA Library
Quantification Kits (KAPA Biosystems) prior to pooling.
Libraries were sequenced on the Illumina HiSeq 2500 or
HiSeq 4000 systems, generating at least 50 million read
pairs (100 million reads) per sample.
Gene expression analyses
Sequencing adapters were removed from reads with
Cutadapt using the Trim Galore! Wrapper script. QC
analyses were carried out using FastQC before and after
adapter trimming, and additionally using RSeQC [59]
after mapping to the GRCh38 human genome reference
sequence with HISAT2 [60]. We used bcftools v1.6 to
call SNPs in the mapping files and compared them to
the imputed genotypes using bcftools gtcheck. Tran-
script abundance was quantified by pseudoalignment of
sequencing reads to transcript sequences derived from the
GRCh38 human genome reference sequence and Ensembl
(version 81) reference annotation using Kallisto [61].
Reads were aggregated at the gene level using tximport
[62] and biomaRt [63]. Between-sample normalization and
variance-stabilizing transformation were carried out
using DESeq2 [64], and genes/transcripts that had
VST-normalized count values > 5 in 10 or more sam-
ples were included in all subsequent analyses. The ex-
pression matrix was quantile-normalized before and
after correcting for covariates (see below), and principal
component analysis was used to assess between-sample
heterogeneity (Additional file 2: Figure S1). The influ-
ence of covariates on gene expression was also quanti-
fied using the variancePartition package in R [65]
(Additional file 2: Figure S2).
eQTL discovery
eQTL analyses were carried out using FastQTL [18],
using quantile normalized gene expression measures
corrected for age, sex, RIN, sequencing batch, the first
three genotype principal components (calculated in
plink1.9, using LD pruned variants (r2 > 0.2 in 250 kb
windows with a step size of 5 kb)), and 10 hidden con-
founders estimated through PEER [17]. FDR for each
eQTL was calculated by first correcting P values for the
number of SNPs tested per gene/transcript (within 1 Mb
either side of the TSS) through estimation of a beta dis-
tribution using a minimum of 1000 permutations (max-
imum 10,000), and then correcting these P values for
the number of genes/transcripts tested using Storey’s q
value method [30]. Details of all steps of these analyses
are available at www.github.com/hobrien/GENEX-FB2.
Comparisons with GTEx adult eQTL data
We obtained multi-tissue meta-analysis results from the
Genotype-Tissue Expression (GTEx) Consortium (V7)
and matched variants by position and alleles. We
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assayed by GTEx from the median TPM results, and de-
termine which genes were expressed in each tissue from
the normalized expression matrices. Of the 1329
cis-eQTL eGenes (FDR < 0.05) identified in fetal brain,
176 were either not assayed (115 genes) or had expres-
sion values below the cut-off in all tissues (61 genes) in
the GTEx study. For a further two fetal eGenes, there
were no significant cis-eQTL that were genotyped by
GTEx. For each eGene that was included in at least one
GTEx expression matrix, we identified the most signifi-
cant eQTL variant from our analysis that was assayed by
GTEx and extracted the meta-analysis results and P
values for those eQTLs. For eQTLs that were detected
in at least two GTEx tissues, we created a heatmap of m
values to show the extent of sharing between fetal brain
and adult GTEx tissues. Tissue sharing was also quanti-
fied by estimating π1 (the proportion of true positives
[30]) among this set of eQTLs in each GTEx tissue.
Spatiotemporal expression of fetal eGenes in human brain
We used RNA sequencing data from dissected regions of
the human pre- and post-natal brain, available through
the BrainSpan project (http://www.brainspan.org/), to ex-
plore the regional and developmental expression of the
fetal eGenes we identified. FPKM values were log trans-
formed (log2[FPKM+ 0.0001]), clustered using Euclidian
distances, and heatmaps were made using ggplot2 [66].
eQTL enrichment analyses
We performed the following enrichment analyses using
GARFIELD [38]:
1) Enrichment of eQTL in functional annotation
categories
2) Enrichment of mQTL in eQTL
3) Enrichment of variants associated with brain and
non-brain complex traits in eQTL
Briefly, GARFIELD tests for enrichment of GWAS as-
sociated variants in annotation categories. The user pro-
vides the GWAS P values for all variants and an
annotation file indicating whether variants are located
within functional categories to be tested. The software
then selects an independent set of variants by sequen-
tially removing variants with r2 > 0.1 within a 1-Mb win-
dow from the most significantly associated variant and
then classifies each variant as overlapping a functional
category if either the variant or a correlated variant (de-
fined as r2 > 0.8) is part of the annotation category. Stat-
istical significance is calculated using a generalized linear
model, while variants are matched by MAF, distance to
the nearest transcription start site, number of LD prox-
ies and CpG and GC content. CpG and GC contentwere calculated for a region 500 bp up and downstream
of the variant using the BSgenome.Hsapiens.UCSC.hg19
R package. All variants from the UK10K were used as
the background set of genetic variants. Depending on
the particular enrichment analysis, our eQTL data were
either considered as the GWAS trait (using the mini-
mum P value across all genes/transcripts tested) or the
annotation, where all variants associated with at least
one gene/transcript at 5% FDR were used to construct
the functional category.Enrichment of fetal brain eQTL in functional annotation
categories
We tested for significant enrichment of eQTLs in vari-
ous functional and regulatory features defined using ex-
perimentally derived annotations from the ENCODE [8]
and Epigenomics Roadmap [9] projects and provided
with the GARFIELD software. Enrichment testing was
performed for fetal brain transcript eQTLs with P values
equivalent to FDR < 0.05. We tested the default of all
features in all assayed cells/tissues (1004 tests), defining
P values below the Bonferroni-corrected threshold of P
< 4.98 × 10− 5 as significant.Enrichment of fetal brain mQTLs in eQTL
To test for enrichment of genetic variants associated with
DNA methylation in the developing brain within fetal
brain eQTL, we used a DNA methylation QTL (mQTL)
dataset that we published previously using an overlapping
set of fetal brain samples [10]. All FDR < 0.05 eQTLs were
used to define an annotation category. Enrichment was
tested using the set of mQTL that we previously identified
at a Bonferroni-corrected threshold P < 3.69 × 10− 13.Enrichment of variants associated with brain and non-brain
complex traits in eQTLs
GWAS results for attention deficit hyperactivity disorder
[31], anorexia nervosa [32], autism spectrum disorder
[33], bipolar disorder [34], major depressive disorder
[35], neuroticism [26], schizophrenia [36], body mass
index [39], coronary artery disease [40], inflammatory
bowel disease [41], height [42], and type 2 diabetes [43]
were downloaded, and the P values for all variants were
reformatted as input to GARFIELD. All 5% FDR eQTLs
for eTranscripts were used to define an annotation cat-
egory. We tested for enrichment in fetal brain eQTLs of
variants associated with each trait at multiple signifi-
cance thresholds (P < 5 × 10− 5, 5 × 10− 6, 5 × 10− 7, 5 ×
10− 8). In total, we tested 12 traits and 4 significance
thresholds, highlighting enrichments that surpassed the
Bonferroni corrected threshold P < 0.001.
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We tested for joint associations between fetal brain eQTL
and GWAS signals using summary-statistics-based Men-
delian randomization (SMR) [44]. We tested all eGenes/
eTranscripts with eQTLs detected at FDR < 0.05, using
linkage disequilibrium information from the samples used
for our eQTL analysis. GWAS minor allele frequencies
were obtained from the 1000 Genomes Project (European
populations). SMR P values were Bonferroni corrected for
the number of eGenes/eTranscripts tested. The HEIDI
test was used to screen out joint associations that are
likely to be driven by linkage using a nominal P value
threshold of 0.05.
We additionally investigated potential sharing of eQTLs
identified by the CommonMind Consortium in the adult
human brain [49] that have been implicated in schizo-
phrenia or neuroticism in the SMR study of Hauberg and
colleagues [45]. For this, we restricted our analyses to the
fetal brain eGenes detected at FDR < 0.05 that overlapped
with those implicated by Hauberg et al. in neuropsychi-
atric traits, and explored potential linkage disequilibrium
between the top adult brain SMR eQTL and the most sig-
nificant fetal brain eQTL for each gene. We report in-
stances where the top adult brain SMR eQTL and the top
eQTL for that gene in fetal brain have an r2 > 0.8 in our
samples, suggesting shared causal variants.
Additional files
Additional file 1: Tables S1-S10. containing sample data, top eQTL for
all significant eGenes and eTranscripts (FDR < 0.05), results of enrichment
analyses and results of SMR analyses in relation to neuropsychiatric traits.
(XLSX 987 kb)
Additional file 2: Figures S1-S8. All supplementary figures. (PDF 1212 kb)
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